Ccnd2 and mir-206 as potential biomarkers in the clinical diagnosis of thyroid carcinoma by fine-needle aspiration cytology

HIGHLIGHTS

• who: Shifa Yuan from the This study was approved by Ethics Committee of Hebei Medical University (Approval No35421), and all patients provided informed consent. The samples were collected from the patients with FNAC of thyroid nodule at Fourth Hospital of Hebei Medical University from January , to December, . Thyroid ultrasound revealed that all patients had thyroid nodules that met the thyroid fineneedle aspiration indications. After pathological diagnosis, patients with thyroid carcinoma were selected as the subjects, including , men and , women have published the research work: CCND2 and miR-206 as potential biomarkers in the clinical diagnosis of thyroid . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.